StockData
Ironwood Pharmaceuticals Inc logo

Ironwood Pharmaceuticals Inc (IRWD) stock

IRWDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3063% below fair value
$4.70−0.01 (-0.21%)

Close on Nov 20, 2026Market cap $776.63MP/E 6.1Yield –

Ironwood Pharmaceuticals pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Ironwood Pharmaceuticals's pe ratio was 6.2× on Nov 10, 2026, against 23.3× a year earlier. Over the last 5 years it ranged from 3.4× to 161.0×, with a median of 13.0×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 10, 20266.2×−16.2
2025Dec 31, 202522.5×−76.3
2024Oct 31, 202498.8×+87.8
2023Jul 31, 202311.0×−2.1
2022Dec 30, 202213.0×+9.5
2021Dec 31, 20213.6×−12.9
2020Dec 31, 202016.5×–

More Ironwood Pharmaceuticals figures

See a number that looks wrong?